These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28390954)

  • 1. The effects of RAMPs upon cell signalling.
    Routledge SJ; Ladds G; Poyner DR
    Mol Cell Endocrinol; 2017 Jul; 449():12-20. PubMed ID: 28390954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor activity-modifying proteins; multifunctional G protein-coupled receptor accessory proteins.
    Hay DL; Walker CS; Gingell JJ; Ladds G; Reynolds CA; Poyner DR
    Biochem Soc Trans; 2016 Apr; 44(2):568-73. PubMed ID: 27068971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles.
    Hay DL; Pioszak AA
    Annu Rev Pharmacol Toxicol; 2016; 56():469-87. PubMed ID: 26514202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAMPs as allosteric modulators of the calcitonin and calcitonin-like class B G protein-coupled receptors.
    Pioszak AA; Hay DL
    Adv Pharmacol; 2020; 88():115-141. PubMed ID: 32416865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural insights into RAMP modification of secretin family G protein-coupled receptors: implications for drug development.
    Archbold JK; Flanagan JU; Watkins HA; Gingell JJ; Hay DL
    Trends Pharmacol Sci; 2011 Oct; 32(10):591-600. PubMed ID: 21722971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of GPCR activity, trafficking and localization by GPCR-interacting proteins.
    Magalhaes AC; Dunn H; Ferguson SS
    Br J Pharmacol; 2012 Mar; 165(6):1717-1736. PubMed ID: 21699508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplexed analysis of the secretin-like GPCR-RAMP interactome.
    Lorenzen E; Dodig-Crnković T; Kotliar IB; Pin E; Ceraudo E; Vaughan RD; Uhlèn M; Huber T; Schwenk JM; Sakmar TP
    Sci Adv; 2019 Sep; 5(9):eaaw2778. PubMed ID: 31555726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying Proteins.
    Kotliar IB; Lorenzen E; Schwenk JM; Hay DL; Sakmar TP
    Pharmacol Rev; 2023 Jan; 75(1):1-34. PubMed ID: 36757898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Itch receptor MRGPRX4 interacts with the receptor activity-modifying proteins.
    Kotliar IB; Ceraudo E; Kemelmakher-Liben K; Oren DA; Lorenzen E; Dodig-Crnković T; Horioka-Duplix M; Huber T; Schwenk JM; Sakmar TP
    J Biol Chem; 2023 May; 299(5):104664. PubMed ID: 37003505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiplexed mapping of the interactome of GPCRs with receptor activity-modifying proteins.
    Kotliar IB; Bendes A; Dahl L; Chen Y; Saarinen M; Ceraudo E; Dodig-Crnković T; Uhlén M; Svenningsson P; Schwenk JM; Sakmar TP
    Sci Adv; 2024 Aug; 10(31):eado9959. PubMed ID: 39083597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GPCRs globally coevolved with receptor activity-modifying proteins, RAMPs.
    Barbash S; Lorenzen E; Persson T; Huber T; Sakmar TP
    Proc Natl Acad Sci U S A; 2017 Nov; 114(45):12015-12020. PubMed ID: 29078385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expanding repertoire of receptor activity modifying protein (RAMP) function.
    Klein KR; Matson BC; Caron KM
    Crit Rev Biochem Mol Biol; 2016; 51(1):65-71. PubMed ID: 26740457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAMPs as drug targets.
    Sexton PM; Poyner DR; Simms J; Christopoulos A; Hay DL
    Adv Exp Med Biol; 2012; 744():61-74. PubMed ID: 22434108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of GPCR trafficking by RAMPs.
    Bomberger JM; Parameswaran N; Spielman WS
    Adv Exp Med Biol; 2012; 744():25-37. PubMed ID: 22434105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dawn of a New RAMPage.
    Serafin DS; Harris NR; Nielsen NR; Mackie DI; Caron KM
    Trends Pharmacol Sci; 2020 Apr; 41(4):249-265. PubMed ID: 32115276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor activity modifying proteins and their potential as drug targets.
    Wootten DL; Simms J; Hay DL; Christopoulos A; Sexton PM
    Prog Mol Biol Transl Sci; 2010; 91():53-79. PubMed ID: 20691959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor Activity Modifying Proteins Have Limited Effects on the Class B G Protein-Coupled Receptor Calcitonin Receptor-Like Receptor Stalk.
    Garelja ML; Walker CA; Siow A; Yang SH; Harris PWR; Brimble MA; Watkins HA; Gingell JJ; Hay DL
    Biochemistry; 2018 Feb; 57(8):1410-1422. PubMed ID: 29388762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G Protein-Coupled Receptors as Potential Intercellular Communication Mediators in Trypanosomatidae.
    Díaz E; Febres A; Giammarresi M; Silva A; Vanegas O; Gomes C; Ponte-Sucre A
    Front Cell Infect Microbiol; 2022; 12():812848. PubMed ID: 35651757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The receptor activity modifying protein family of G protein coupled receptor accessory proteins.
    Udawela M; Hay DL; Sexton PM
    Semin Cell Dev Biol; 2004 Jun; 15(3):299-308. PubMed ID: 15125893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulating receptor function through RAMPs: can they represent drug targets in themselves?
    Sexton PM; Poyner DR; Simms J; Christopoulos A; Hay DL
    Drug Discov Today; 2009 Apr; 14(7-8):413-9. PubMed ID: 19150656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.